Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.88 USD | +6.52% | +28.64% | +126.80% |
Mar. 06 | Transcript : Inovio Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 06, 2024 | |
Mar. 06 | Inovio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 604K | Sales 2025 * | 8.03M | Capitalization | 324M |
---|---|---|---|---|---|
Net income 2024 * | -99M | Net income 2025 * | -93M | EV / Sales 2024 * | 537 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 40.4 x |
P/E ratio 2024 * |
-3.6
x | P/E ratio 2025 * |
-4.6
x | Employees | 122 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.39% |
Latest transcript on Inovio Pharmaceuticals, Inc.
1 day | +6.52% | ||
1 week | +28.64% | ||
Current month | +56.66% | ||
1 month | +53.88% | ||
3 months | +125.52% | ||
6 months | +203.03% | ||
Current year | +126.80% |
Managers | Title | Age | Since |
---|---|---|---|
Jacqueline Shea
CEO | Chief Executive Officer | 58 | 19-03-24 |
Peter Kies
DFI | Director of Finance/CFO | 60 | 02-05-31 |
Chief Tech/Sci/R&D Officer | - | 07-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Benito
CHM | Chairman | 79 | 03-11-30 |
Lota Zoth
BRD | Director/Board Member | 64 | 17-12-31 |
Jay Shepard
BRD | Director/Board Member | 66 | 20-01-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 13.88 | +6.52% | 893,803 |
24-03-27 | 13.03 | +5.25% | 292,412 |
24-03-26 | 12.38 | -0.16% | 590,612 |
24-03-25 | 12.4 | +6.71% | 558,729 |
24-03-22 | 11.62 | +5.83% | 558,456 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+126.80% | 305M | |
+9.30% | 45.97B | |
+52.73% | 43.93B | |
+7.15% | 42.34B | |
-8.78% | 28.27B | |
+18.68% | 27.18B | |
-21.92% | 19.44B | |
+14.62% | 13.83B | |
+31.85% | 12.4B | |
+4.47% | 11.45B |